|
Volumn 83, Issue SUPPL. 1, 2003, Pages 119-133
|
Carcinoma of the fallopian tube
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HORMONE ANALOG;
ANATOMICAL VARIATION;
CANCER ADJUVANT THERAPY;
CANCER CLASSIFICATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CYTODIAGNOSIS;
CANCER EPIDEMIOLOGY;
CANCER GRADING;
CANCER HORMONE THERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CARCINOMA IN SITU;
DATA ANALYSIS;
DIAGNOSTIC APPROACH ROUTE;
DIAGNOSTIC IMAGING;
DIAGNOSTIC TEST;
HUMAN;
INFORMATION RETRIEVAL;
LIFE EXPECTANCY;
MEDICAL RECORD;
OVARY CARCINOMA;
POSTMENOPAUSE;
PRIORITY JOURNAL;
REVIEW;
SURVIVAL RATE;
UTERINE TUBE CARCINOMA;
ADULT;
AGE DISTRIBUTION;
AGED;
ARTICLE;
CANCER STAGING;
CARCINOMA;
FEMALE;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
UTERINE TUBE TUMOR;
ADULT;
AGE DISTRIBUTION;
AGED;
AGED, 80 AND OVER;
CARCINOMA;
FALLOPIAN TUBE NEOPLASMS;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM STAGING;
SURVIVAL RATE;
|
EID: 10644253573
PISSN: 00207292
EISSN: None
Source Type: Journal
DOI: 10.1016/S0020-7292(03)90117-2 Document Type: Note |
Times cited : (13)
|
References (0)
|